Delivery of hydrophobic molecules and proteins has been an issue due to poor bioavailability following administration. Thus, micelle carrier systems are being investigated to improve drug solubility and stability. Due to problems with toxicity and immunogenicity, natural polysaccharides are being explored as substitutes for synthetic polymers in the development of new micelle systems. By grafting hydrophobic moieties to the polysaccharide backbone, self-assembled micelles can be readily formed in aqueous solution. Many polysaccharides also possess inherent bioactivity that can facilitate mucoadhesion, enhanced targeting of specific tissues, and a reduction in the inflammatory response. Furthermore, the hydrophilic nature of some polysaccharides can be exploited to enhance circulatory stability. This review will highlight the advantages of polysaccharide use in the development of drug delivery systems and will provide an overview of the polysaccharide-based micelles that have been developed to date.
Liu, R. Water-Insoluble Drug Formulation, 2nd ed. ed.; CRC Press: Boca Raton, FL, USA, 2008; p. 669.
[3]
Torchilin, V.P. Nanoparticulates as Drug Carriers, 1st ed. ed.; World Scientific Publishing Company: London, UK/Hackensack, NJ, USA, 2006; p. 724.
[4]
Torchilin, V.P. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell. Mol. Life Sci. 2004, 61, 2549–2559, doi:10.1007/s00018-004-4153-5.
[5]
Bader, H.; Ringsdorf, H.; Schmidt, B. Watersoluble Polymers in Medicine. Angew. Makromol. Chem. 1984, 123, 457–485, doi:10.1002/apmc.1984.051230121.
[6]
Torchilin, V.P. Drug targeting. Eur. J. Pharm. Sci. 2000, 11, S81–S91, doi:10.1016/S0928-0987(00)00166-4.
[7]
Xiong, X.B.; Falamarzian, A.; Garg, S.M.; Lavasanifar, A. Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery. J. Contr. Release 2011, 155, 248–261, doi:10.1016/j.jconrel.2011.04.028.
Liao, Y.H.; Jones, S.A.; Forbes, B.; Martin, G.P.; Brown, M.B. Hyaluronan: Pharmaceutical characterization and drug delivery. Drug Deliv. 2005, 12, 327–342, doi:10.1080/10717540590952555.
[11]
Shukla, R.K.; Tiwari, A. Carbohydrate polymers: Applications and recent advances in delivering drugs to the colon. Carbohydr. Polym. 2012, 88, 399–416, doi:10.1016/j.carbpol.2011.12.021.
[12]
Liu, Z.; Jiao, Y.; Wang, Y.; Zhou, C.; Zhang, Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv. Rev. 2008, 60, 1650–1662, doi:10.1016/j.addr.2008.09.001.
[13]
Saravanakumar, G.; Jo, D.G.; Park, J.H. Polysaccharide based nanoparticles: A versatile Platform for Drug Delivery and Biomedical Imaging. Curr. Med. Chem. 2012, 19, 3212–3219, doi:10.2174/092986712800784658.
[14]
Dang, J.M.; Leong, K.W. Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev. 2006, 58, 487–499, doi:10.1016/j.addr.2006.03.001.
[15]
Ratner, B.D.; Bryant, S.J. Biomaterials: Where we have been and where we are going. Annu. Rev. Biomed. Eng. 2004, 6, 41–75, doi:10.1146/annurev.bioeng.6.040803.140027.
[16]
Chen, J.; Jo, S.; Park, K. Polysaccharide hydrogels for protein drug delivery. Carbohydr. Polym. 1995, 28, 69–76.
[17]
Mizrahy, S.; Peer, D. Polysaccharides as building blocks for nanotherapeutics. Chem. Soc. Rev. 2012, 41, 2623–2640, doi:10.1039/c1cs15239d.
[18]
Coviello, T.; Matricardi, P.; Marianecci, C.; Alhaique, F. Polysaccharide hydrogels for modified release formulations. J. Contr. Release 2007, 119, 5–24, doi:10.1016/j.jconrel.2007.01.004.
[19]
Cadée, J.A.; Brouwer, L.A.; den Otter, W.; Hennick, W.E.; van Luyn, M.J. A comparative biocompatibiltiy study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats. J. Biomed. Mater. Res. 2001, 56, 600–609, doi:10.1002/1097-4636(20010915)56:4<600::AID-JBM1133>3.0.CO;2-I.
[20]
Jain, A.; Gupta, Y.; Jain, S.K. Perspectives of biodegradable natural polysaccharides for site specific drug delivery to the colon. J.Pharm. Pharm. Sci. 2007, 10, 86–128.
[21]
Rempel, B.P.; Withers, S.G. Covalent inhibitors of glycosidases and their applications in biochemistry and biology. Glycobiology 2008, 18, 570–586, doi:10.1093/glycob/cwn041.
[22]
Mehvar, R. Recent trends in the use of polysaccharides for improved delivery of therapeutic agents: Pharmacokinetic and Pharmacodynamic perspectives. Curr. Pharm. Biotechnol. 2003, 4, 283–302, doi:10.2174/1389201033489685.
[23]
Lim, S.M.; Song, D.K.; Oh, S.H.; Lee-Yoon, D.S.; Bae, E.H.; Lee, J.H. In vitro and in vivo degradation behavior of acetylated chitosan porous beads. J. Biomater. Sci. Polym. Ed. 2008, 19, 453–466, doi:10.1163/156856208783719482.
[24]
Dash, M.; Chiellini, F.; Ottenbrite, R.M.; Chiellini, E. Chitosan—A versatile semi-synthetic polymer in biomedical applications. Prog. Polym. Sci. 2011, 36, 981–1014, doi:10.1016/j.progpolymsci.2011.02.001.
[25]
Morris, G.A. Polysaccharide drug delivery systems based on pectin and chitosan. Biotechnol. Genet. Eng. Rev. 2010, 27, 257–283, doi:10.1080/02648725.2010.10648153.
[26]
Alonso-Sande, M.; Teijeiro-Osorio, D.; Remu？án-López, C.; Alonso, M.J. Glucomannan, a promising polysaccharide for biopharmaceutical purposes. Eur. J. Pharm. Biopharm. 2009, 72, 453–462, doi:10.1016/j.ejpb.2008.02.005.
[27]
Mourya, V.K.; Inamdar, N.N. Trimethyl chitosan and its application in drug delivery. J. Mater. Sci. Mater. Med. 2009, 20, 1057–1079.
[28]
Thanou, M.; Verhoef, J.C.; Junginger, H.E. Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev. 2001, 52, 117–126, doi:10.1016/S0169-409X(01)00231-9.
[29]
Thanou, M.; Verhoef, J.C.; Junginger, H.E. Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Deliv. Rev. 2001, 50, S91–S101, doi:10.1016/S0169-409X(01)00180-6.
[30]
Bernkop-Schnürch, A.; Dünnhaupt, S. Chitosan-based drug delivery systems. Eur. J. Pharm. Biopharm. 2012, 81, 463–469, doi:10.1016/j.ejpb.2012.04.007.
[31]
Boddhoi, S.; Killingsworth, C.E.; Kipper, M.J. Polyelectrolyte multilayer assembly as a function of pH and ionic strength using the polysaccharides chitosan and heparin. Biomacromolecules 2008, 9, 2021–2028, doi:10.1021/bm8002573.
[32]
Bonferoni, M.C.; Sandri, G.; Ferrari, F.; Rossi, S.; Larghi, V.; Zambito, Y.; Caramella, C. Comparison of different in vitro and ex vivo methods to evaluate mucoadhesion of glycol-palmitoyl chitosan micelles. J. Drug Del. Sci. Tech. 2010, 20, 419–424.
[33]
Reddy, K.; Mohan, G.K.; Satla, S.; Gaikwad, S. Natural Polysaccharides: Versatile Excipients for controlled drug delivery systems. J. Pharm. Sci. 2011, 6, 275–286.
[34]
Dai, T.; Tanaka, M.; Huang, Y.Y.; Hamblin, M.R. Chitosan preparations for wounds and burns: Antimicrobial and wound healing effects. Expert Rev. Anti Infect. Ther. 2011, 9, 857–879, doi:10.1586/eri.11.59.
[35]
Young, E. The anti-inflammatory effects of heparin and related compounds. Thromb. Res. 2008, 122, 743–752, doi:10.1016/j.thromres.2006.10.026.
[36]
Olson, S.T.; Srinivasan, K.R.; Bjork, I.; Shore, J.D. Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction. J. Biol. Chem. 1981, 256, 11073–11079.
[37]
Olson, S.T.; Shore, J.D. Binding of high affinity heparin to antithrombin III. Characterization of the protein fluorescence enhancement. J. Biol. Chem. 1981, 256, 11065–11072.
[38]
Akiyoshi, K.; Sasaki, Y.; Sunamoto, J. Molecular chaperone-like activity of hydrogel nanoparticles of hydrophobized pullulan: Thermal stabilization with refolding of carbonic anhydrase B. Bioconjug. Chem. 1999, 10, 321–324, doi:10.1021/bc9801272.
[39]
Sunamoto, J.; Akiyoshi, K.; Deguchi, S.; Kato, Y.; Taniguchii, I.; Sasaki, Y.; Kuroda, K. Hydrogel nanoparticles formed by self-aggregation of hydrophobized polysaccharides. Abstr. Pap. Am. Chem. S 1998, 216, U831–U831.
[40]
Akiyoshi, K.; Deguchi, S.; Moriguchi, N.; Yamaguchi, S.; Sunamoto, J. Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles. Macromolecules 1993, 26, 3062–3068, doi:10.1021/ma00064a011.
[41]
Morimoto, N.; Nomura, S.I.M.; Miyazawa, N.; Akiyoshi, K. Nanogel engineered designs for polymeric drug delivery. ACS Sym. Ser. 2006, 924, 88–101, doi:10.1021/bk-2006-0924.ch006.
Lee, K.Y.; Jo, W.H.; Kwon, I.C.; Kim, Y.H.; Jeong, S.Y. Structural determination and interior polarity of self-aggregates prepared from deoxycholic acid-modified chitosan in water. Macromolecules 1998, 31, 378–383, doi:10.1021/ma9711304.
[44]
Nichifor, M.; Lopes, A.; Carpov, A.; Melo, E. Aggregation in water of dextran hydrophobically modified with bile acids. Macromolecules 1999, 32, 7078–7085.
Akiyoshi, K.; Yamaguchi, S.; Sunamoto, J. Self-aggregates of hydrophobic polysaccharide derivatives. Chem. Lett. 1991, 1263–1266, doi:10.1246/cl.1991.1263.
[47]
Akiyoshi, K.; Kobayashi, S.; Shichibe, S.; Mix, D.; Baudys, M.; Kim, S.W.; Sunamoto, J. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin. J. Contr. Release 1998, 54, 313–320, doi:10.1016/S0168-3659(98)00017-0.
[48]
Akiyoshi, K.; Nishikawa, T.; Shichibe, S.; Sunamoto, J. Stabilization of insulin upon supramolecular complexation with hydrophobized polysaccharide nanoparticle. Chem. Lett. 1995, 24, 707–708.
[49]
Kobayashi, H.; Katakura, O.; Morimoto, N.; Akiyoshi, K.; Kasugai, S. Effects of cholesterol-bearing pullulan (CHP)-nanogels in combination with prostaglandin E1 on wound healing. J. Biomed. Mater. Res. Part B 2009, 91B, 55–60, doi:10.1002/jbm.b.31373.
[50]
Satoh, K.; Chen, F.; Aoyama, A.; Date, H.; Akiyoshi, K. Nanoparticle of cholesterol-bearing pullulan as a carrier of anticancer drugs. EJC Suppl. 2008, 6, 139–139.
Kageyama, S.; Kitano, S.; Hirayama, M.; Nagata, Y.; Imai, H.; Shiraishi, T.; Akiyoshi, K.; Scott, A.M.; Murphy, R.; Hoffman, E.W.; et al. Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel. Cancer Sci. 2008, 99, 601–607, doi:10.1111/j.1349-7006.2007.00705.x.
[53]
Miyahara, T.; Nyan, M.; Shimoda, A.; Yamamoto, Y.; Kuroda, S.; Shiota, M.; Akiyoshi, K.; Kasugai, S. Exploitation of a novel polysaccharide nanogel cross-linking membrane for guided bone regeneration (GBR). J. Tissue Eng. Regen. Med. 2012, 6, 666–672, doi:10.1002/term.475.
[54]
Akiyama, E.; Morimoto, N.; Kujawa, P.; Ozawa, Y.; Winnik, F.M.; Akiyoshi, K. Self-assembled nanogels of cholesteryl-modified polysaccharides: Effect of the polysaccharide structure on their association characteristics in the dilute and semidilute regimes. Biomacromolecules 2007, 8, 2366–2373, doi:10.1021/bm070136q.
[55]
Nagahama, K.; Ouchi, T.; Ohya, Y. Biodegradable nanogels prepared by self-assembly of poly(L-lactide)-grafted dextran: Entrapment and release of proteins. Macromol. Biosci. 2008, 8, 1044–1052, doi:10.1002/mabi.200800175.
[56]
Morimoto, N.; Hirano, S.; Takahashi, H.; Loethen, S.; Thompson, D.H.; Akiyoshi, K. Self-assembled pH-sensitive cholesteryl pullulan nanogel as a protein delivery vehicle. Biomacromolecules 2013, 14, 56–63, doi:10.1021/bm301286h.
[57]
Fujioka-Kobayashi, M.; Ota, M.S.; Shimoda, A.; Nakahama, K.; Akiyoshi, K.; Miyamoto, Y.; Iseki, S. Cholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineering. Biomaterials 2012, 33, 7613–7620, doi:10.1016/j.biomaterials.2012.06.075.
[58]
Wang, X.H.; Tian, Q.; Wang, W.; Zhang, C.N.; Wang, P.; Yuan, Z. In vitro evaluation of polymeric micelles based on hydrophobically-modified sulfated chitosan as a carrier of doxorubicin. J. Mater. Sci. Mater. Med. 2012, 23, 1663–1674, doi:10.1007/s10856-012-4627-1.
[59]
Ngawhirunpat, T.; Wonglertnirant, N.; Opanasopit, P.; Ruktanonchai, U.; Yoksan, R.; Wasanasuk, K.; Chirachanchai, S. Incorporation methods for cholic acid chitosan-g-mPEG self-assembly micellar system containing camptothecin. Colloids Surf. B Biointerfaces 2009, 74, 253–259, doi:10.1016/j.colsurfb.2009.07.027.
[60]
Xiong, Y.; Qi, J.; Yao, P. Amphiphilic cholic-acid-modified dextran sulfate and its application for the controlled delivery of superoxide dismutase. Macromol. Biosci. 2012, 12, 515–524, doi:10.1002/mabi.201100367.
[61]
Khatun, Z.; Nurunnabi, M.; Cho, K.J.; Lee, Y.K. Oral delivery of near-infrared quantum dot loaded micelles for noninvasive biomedical imaging. ACS Appl. Mater. Interfaces 2012, 4, 3880–3887, doi:10.1021/am301048m.
[62]
Park, K.; Kim, K.; Kwon, I.C.; Kim, S.K.; Lee, S.; Lee, D.Y.; Byun, Y. Preparation and characterization of self-assembled nanoparticles of heparin-deoxycholic acid conjugates. Langmuir 2004, 20, 11726–11731.
[63]
Li, J.; Huo, M.; Wang, J.; Zhou, J.; Mohammad, J.M.; Zhang, Y.; Zhu, Q.; Waddad, A.Y.; Zhang, Q. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials 2012, 33, 2310–2320.
[64]
Wang, F.H.; Zhang, D.R.; Duan, C.X.; Jia, L.J.; Feng, F.F.; Liu, Y.; Wang, Y.C.; Hao, L.L.; Zhang, Q.A. Preparation and characterizations of a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid conjugates and self-aggregates. Carbohydr. Polym. 2011, 84, 1192–1200, doi:10.1016/j.carbpol.2011.01.017.
Jin, Y.H.; Hu, H.Y.; Qiao, M.X.; Zhu, J.; Qi, J.W.; Hu, C.J.; Zhang, Q.; Chen, D.W. pH-Sensitive chitosan-derived nanoparticles as doxorubicin carriers for effective anti-tumor activity: Preparation and in vitro evaluation. Colloids Surf. B Biointerfaces 2012, 94, 184–191, doi:10.1016/j.colsurfb.2012.01.032.
[67]
Lee, J.; Lee, C.; Kim, T.H.; Lee, E.S.; Shin, B.S.; Chi, S.C.; Park, E.S.; Lee, K.C.; Youn, Y.S. Self-assembled glycol chitosan nanogels containing palmityl-acylated exendin-4 peptide as a long-acting anti-diabetic inhalation system. J. Contr. Release 2012, 161, 728–734, doi:10.1016/j.jconrel.2012.05.029.
[68]
Wang, F.; Chen, Y.; Zhang, D.; Zhang, Q.; Zheng, D.; Hao, L.; Liu, Y.; Duan, C.; Jia, L.; Liu, G. Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micelles. Int. J. Nanomed. 2012, 7, 325–337.
[69]
Li, H.; Huo, M.; Zhou, J.; Dai, Y.; Deng, Y.; Shi, X.; Masoud, J. Enhanced oral absorption of paclitaxel in N-deoxycholic acid-N,O-hydroxyethyl chitosan micellar system. J. Pharm. Sci. 2010, 99, 4543–4553, doi:10.1002/jps.22159.
[70]
Kim, Y.H.; Gihm, S.H.; Park, C.R.; Lee, K.Y.; Kim, T.W.; Kwon, I.C.; Chung, H.; Jeong, S.Y. Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier. Bioconjug. Chem. 2001, 12, 932–938.
[71]
Seo, S.; Lee, C.S.; Jung, Y.S.; Na, K. Thermo-sensitivity and triggered drug release of polysaccharide nanogels derived from pullulan-g-poly(l-lactide) copolymers. Carbohydr. Polym. 2012, 87, 1105–1111, doi:10.1016/j.carbpol.2011.08.061.
[72]
Dong, H.; Xu, Q.; Li, Y.; Mo, S.; Cai, S.; Liu, L. The synthesis of biodegradable graft copolymer cellulose-graft-poly(l-lactide) and the study of its controlled drug release. Colloids Surf. B Biointerfaces 2008, 66, 26–33, doi:10.1016/j.colsurfb.2008.05.007.
[73]
Lee, C.T.; Huang, C.P.; Lee, Y.D. Preparation of amphiphilic poly(l-lactide)-graft-chondroitin sulfate copolymer self-aggregates and its aggregation behavior. Biomacromolecules 2006, 7, 1179–1186, doi:10.1021/bm050995j.
[74]
Nagahama, K.; Mori, Y.; Ohya, Y.; Ouchi, T. Biodegradable nanogel formation of polylactide-grafted dextran copolymer in dilute aqueous solution and enhancement of its stability by stereocomplexation. Biomacromolecules 2007, 8, 2135–2141, doi:10.1021/bm070206t.
[75]
Guo, Y.; Wang, X.; Shu, X.; Shen, Z.; Sun, R.C. Self-assembly and paclitaxel loading capacity of cellulose-graft-poly(lactide) nanomicelles. J. Agric. Food Chem. 2012, 60, 3900–3908.
[76]
Ouchi, T.; Minari, T.; Ohya, Y. Synthesis of poly(l-lactide)-grafted pullulan through coupling reaction between amino end-capped poly(l-lactide) and carboxymethyl pullulan and its aggregation behavior in water. J. Polym. Sci. A Polym. Chem. 2004, 42, 5482–5487, doi:10.1002/pola.20336.
[77]
Jeong, Y.I.; Na, H.S.; Oh, J.S.; Choi, K.C.; Song, C.E.; Lee, H.C. Adriamycin release from self-assembling nanospheres of poly(dl-lactide-co-glycolide)-grafted pullulan. Int. J. Pharm. 2006, 322, 154–160, doi:10.1016/j.ijpharm.2006.05.020.
[78]
Jeong, Y.I.; Kim, O.H.; Chung, C.-W.; Yoo, J.-J.; Choi, K.H.; Kim, C.H.; Ha, S.H.; Kang, D.H. Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(dl-lactide-co-glycolide) copolymer. Int. J. Nanomed. 2011, 6, 1415–1427.
[79]
Zhou, Y.Y.; Du, Y.Z.; Wang, L.; Yuan, H.; Zhou, J.P.; Hu, F.Q. Preparation and pharmacodynamics of stearic acid and poly (lactic-co-glycolic acid) grafted chitosan oligosaccharide micelles for 10-hydroxycamptothecin. Int. J. Pharm. 2010, 393, 143–151.
[80]
Bang, J.Y.; Song, C.E.; Kim, C.; Park, W.D.; Cho, K.R.; Kim, P.I.; Lee, S.R.; Chung, W.T.; Choi, K.C. Cytotoxicity of amphotericin B-incorporated polymeric micelles composed of poly(dl-lactide-co-glycolide)/dextran graft copolymer. Arch. Pharm. Res. 2008, 31, 1463–1469.
[81]
Lee, H.; Ahn, C.H.; Park, T.G. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin. Macromol. Biosci. 2009, 9, 336–342, doi:10.1002/mabi.200800229.
[82]
Jeong, Y.I.; Kim, O.H.; Chung, C.W.; Yoo, J.J.; Choi, K.H.; Kim, C.H.; Ha, S.H.; Kang, D.H. Self-assembled nanoparticles of hyaluronic acid/poly(dl-lactide-co-glycolide) block copolymer. Colloids Surf. B Biointerfaces 2012, 90, 28–35, doi:10.1016/j.colsurfb.2011.09.043.
[83]
Dahmani, F.Z.; Yang, H.; Zhou, J.P.; Yao, J.; Zhang, T.; Zhang, Q. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: Preparation, in vitro and in vivo evaluation. Eur. J. Pharm. Sci. 2012, 47, 179–189.
[84]
Choi, J.H.; Jang, J.Y.; Joung, Y.K.; Kwon, M.H.; Park, K.D. Intracellular delivery and anti-cancer effect of self-assembled heparin-Pluronic nanogels with RNase A. J. Contr. Release 2010, 147, 420–427, doi:10.1016/j.jconrel.2010.07.118.
[85]
Malingre, M.M.; Beijnen, J.H.; Schellens, J.H.M. Oral delivery of taxanes. Investig. New Drugs 2001, 19, 155–162, doi:10.1023/A:1010635000879.
[86]
Chiappetta, D.A.; Sosnik, A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs. Eur. J. Pharm. Biopharma. 2007, 66, 303–317.
[87]
Tian, J.L.; Zhao, Y.Z.; Jin, Z.; Lu, C.T.; Tang, Q.Q.; Xiang, Q.; Sun, C.Z.; Zhang, L.; Xu, Y.Y.; Gao, H.S.; et al. Synthesis and characterization of Poloxamer 188-grafted heparin copolymer. Drug Dev. Ind. Pharm. 2010, 36, 832–838, doi:10.3109/03639040903520983.
[88]
Park, K.M.; Bae, J.W.; Joung, Y.K.; Shin, J.W.; Park, K.D. Nanoaggregate of thermosensitive chitosan-Pluronic for sustained release of hydrophobic drug. Colloids Surf. B Biointerfaces 2008, 63, 1–6, doi:10.1016/j.colsurfb.2007.10.024.
[89]
Nguyen, D.H.; Joung, Y.K.; Choi, J.H.; Moon, H.T.; Park, K.D. Targeting ligand-functionalized and redox-sensitive heparin-Pluronic nanogels for intracellular protein delivery. Biomed. Mater. 2011, 6, 055004, doi:10.1088/1748-6041/6/5/055004.
[90]
Huang, S.J.; Sun, S.L.; Feng, T.H.; Sung, K.H.; Lui, W.L.; Wang, L.F. Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier. Eur. J. Pharm. Sci. 2009, 38, 64–73, doi:10.1016/j.ejps.2009.06.002.
[91]
Lee, J.H.; Lee, H.; Joung, Y.K.; Jung, K.H.; Choi, J.H.; Lee, D.H.; Park, K.D.; Hong, S.S. The use of low molecular weight heparin-pluronic nanogels to impede liver fibrosis by inhibition the TGF-beta/Smad signaling pathway. Biomaterials 2011, 32, 1438–1445.
[92]
Manaspon, C.; Viravaidya-Pasuwat, K.; Pimpha, N. Preparation of folate-conjugated pluronic f127/chitosan core-shell nanoparticles encapsulating doxorubicin for breast cancer treatment. J. Nanomater. 2012, 2012, 593878:1–593878:11.
[93]
Zhang, H.W.; Cai, G.Q.; Tang, G.P.; Wang, L.Q.; Jiang, H.L. Synthesis, self-assembly, and cytotoxicity of well-defined trimethylated chitosan-O-poly(epsilon-caprolactone): Effect of chitosan molecular weight. J. Biomed. Mater. Res. B 2011, 98B, 290–299, doi:10.1002/jbm.b.31851.
[94]
Chen, C.; Cai, G.Q.; Zhang, H.W.; Jiang, H.L.; Wang, L.Q. Chitosan-poly(epsilon-caprolactone)-poly(ethylene glycol) graft copolymers: Synthesis, self-assembly, and drug release behavior. Jo. Biomed. Mater. Res. Part A 2011, 96A, 116–124, doi:10.1002/jbm.a.32965.
[95]
Liu, J.Y.; Zhang, L.M. Preparation of a polysaccharide-polyester diblock copolymer and its micellar characteristics. Carbohydr. Polym. 2007, 69, 196–201, doi:10.1016/j.carbpol.2006.09.009.
[96]
Shi, R.W.; Burt, H.M. Synthesis and characterization of amphiphilic hydroxypropylcellulose-graft-poly(epsilon-caprolactone). J. Appl. Polym. Sci. 2003, 89, 718–727, doi:10.1002/app.12194.
[97]
Lin, Y.J.; Liu, Y.S.; Yeh, H.H.; Cheng, T.L.; Wang, L.F. Self-assembled poly(epsilon-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cells. Int. J. Nanomed. 2012, 7, 4169–4183.
[98]
Chen, C.H.; Cuong, N.V.; Chen, Y.T.; So, R.C.; Liau, I.; Hsieh, M.F. Overcoming multidrug resistance of breast cancer cells by the micellar doxorubicin nanoparticles of mPEG-PCL-graft-cellulose. J. Nanosci. Nanotechnol. 2011, 11, 53–60.
[99]
Duan, K.; Zhang, X.; Tang, X.; Yu, J.; Liu, S.; Wang, D.; Li, Y.; Huang, J. Fabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecin. Colloids Surf. B Biointerfaces 2010, 76, 475–482, doi:10.1016/j.colsurfb.2009.12.007.
[100]
Hsieh, M.F.; Cuong, N.V.; Chen, C.H.; Chen, Y.T.; Yeh, J.M. Nano-sized micelles of block copolymers of methoxy poly(ethylene glycol)-poly(epsilon-caprolactone)-graft-2-hydroxyethyl cellulose for doxorubicin delivery. J. Nanosci. Nanotechnol. 2008, 8, 2362–2368, doi:10.1166/jnn.2008.322.
[101]
Sahu, S.K.; Maiti, S.; Maiti, T.K.; Ghosh, S.K.; Pramanik, P. Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel. J. Drug Target. 2011, 19, 104–113, doi:10.3109/10611861003733987.
[102]
Huang, X.; Jiang, X.H.; Hu, F.Q.; Du, Y.Z.; Zhu, Q.F.; Jin, C.S. In vitro antitumour activity of stearic acid-g-chitosan oligosaccharide polymeric micelles loading podophyllotoxin. J. Microencapsul. 2012, 29, 1–8, doi:10.3109/02652048.2011.621551.
[103]
Huang, S.T.; Du, Y.Z.; Yuan, H.; Zhang, X.G.; Miao, J.; Cui, F.D.; Hu, F.Q. Synthesis and anti-hepatitis B virus activity of acyclovir conjugated stearic acid-g-chitosan oligosaccharide micelle. Carbohydr. Polym. 2011, 83, 1715–1722, doi:10.1016/j.carbpol.2010.10.032.
[104]
Yuan, H.; Lu, L.J.; Du, Y.Z.; Hu, F.Q. Stearic acid-g-chitosan polymeric micelle for oral drug delivery: In vitro transport and in vivo absorption. Mol. Pharma. 2011, 8, 225–238, doi:10.1021/mp100289v.
Hu, F.Q.; Liu, L.N.; Du, Y.Z.; Yuan, H. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. Biomaterials 2009, 30, 6955–6963, doi:10.1016/j.biomaterials.2009.09.008.
[112]
Jung, S.W.; Jeong, Y.I.; Kim, S.H. Characterization of hydrophobized pullulan with various hydrophobicities. Int. J. Pharm. 2003, 254, 109–121, doi:10.1016/S0378-5173(03)00006-1.
[113]
Lu, D.X.; Wen, X.T.; Liang, J.; Gu, Z.W.; Zhang, X.D.; Fan, Y.J. A pH-sensitive nano drug delivery system derived from pullulan/doxorubicin conjugate. J. Biomed. Mater. Res. Part B Appl Biomater. 2009, 89B, 177–183, doi:10.1002/jbm.b.31203.
[114]
Park, K.H.; Kang, D.; Na, K. Physicochemical characterization and carcinoma cell interaction of self-organized nanogels prepared from polysaccharide/biotin conjugates for development of anticancer drug carrier. J. Microbiol. Biotechnol. 2006, 16, 1369–1376.
[115]
Kamel, S.; Ali, N.; Jahangir, K.; Shah, S.M.; El-Gendy, A.A. Pharmaceutical significance of cellulose: A review. Exp. Polym. Lett. 2008, 2, 758–778, doi:10.3144/expresspolymlett.2008.90.
[116]
Francis, M.F.; Piredda, M.; Winnik, F.M. Solubilization of poorly water soluble drugs in micelles of hydrophobically modified hydroxypropylcellulose copolymers. J. Contr. Release 2003, 93, 59–68, doi:10.1016/j.jconrel.2003.08.001.
[117]
Chayed, S.; Winnik, F.M. In vitro evaluation of the mucoadhesive properties of polysaccharide-based nanoparticulate oral drug delivery systems. Eur. J. Pharma. Biopharm. 2007, 65, 363–370, doi:10.1016/j.ejpb.2006.08.017.
[118]
Francis, M.F.; Cristea, M.; Yang, Y.L.; Winnik, F.M. Engineering polysaccharide-based polymeric micelles to enhance permeability of cyclosporin a across Caco-2 cells. Pharma. Res. 2005, 22, 209–219, doi:10.1007/s11095-004-1188-0.
[119]
Enomoto-Rogers, Y.; Kamitakahara, H.; Yoshinaga, A.; Takano, T. Synthesis of diblock copolymers with cellulose derivatives 4. Self-assembled nanoparticles of amphiphilic cellulose derivatives carrying a single pyrene group at the reducing-end. Cellulose 2011, 18, 1005–1014, doi:10.1007/s10570-011-9549-4.
Francis, M.F.; Lavoie, L.; Winnik, F.M.; Leroux, J.C. Solubilization of cyclosporin A in dextran-g-polyethyleneglycolalkyl ether polymeric micelles. Eur. J. Pharm. Biopharm. 2003, 56, 337–346, doi:10.1016/S0939-6411(03)00111-5.
[122]
Francis, M.F.; Cristea, M.; Winnik, F.M. Exploiting the vitamin B-12 pathway to enhance oral drug delivery via polymeric micelles. Biomacromolecules 2005, 6, 2462–2467, doi:10.1021/bm0503165.
Yuan, X.B.; Li, H.; Zhu, X.X.; Woo, H.G. Self-aggregated nanoparticles composed of periodate-oxidized dextran and cholic acid: Preparation, stabilization and in-vitro drug release. J. Chem. Technol. Biotechnol. 2006, 81, 746–754.
[125]
Xu, Q.G.; Yuan, X.B.; Chang, J. Self-aggregates of cholic acid hydrazide-dextran conjugates as drug carriers. J. Appl. Polym. Sci. 2005, 95, 487–493.
[126]
Houga, C.; Giermanska, J.; Lecommandoux, S.; Borsali, R.; Taton, D.; Gnanou, Y.; Le Meins, J.F. Micelles and polymersomes obtained by self-assembly of dextran and polystyrene based block copolymers. Biomacromolecules 2009, 10, 32–40.
[127]
Daoud-Mahammed, S.; Couvreur, P.; Bouchemal, K.; Cheron, M.; Lebas, G.; Amiel, C.; Gref, R. Cyclodextrin and polysaccharide-based nanogels: Entrapment of two hydrophobic molecules, benzophenone and tamoxifen. Biomacromolecules 2009, 10, 547–554.
Tian, Q.; Wang, X.H.; Wang, W.; Zhang, C.N.; Wang, P.; Yuan, Z. Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid. Nanomed. Nanotechnol. Biol. Med. 2012, 8, 870–879.
[130]
Mo, R.; Jin, X.; Li, N.; Ju, C.Y.; Sun, M.J.; Zhang, C.; Ping, Q.N. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Biomaterials 2011, 32, 4609–4620.
[131]
Lian, H.; Sun, J.; Yu, Y.P.; Liu, Y.H.; Cao, W.; Wang, Y.J.; Sun, Y.H.; Wang, S.L.; He, Z.G. Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery. Int. J. Nanomed. 2011, 6, 3323–3334.
[132]
Du, Y.Z.; Wang, L.; Yuan, H.; Hu, F.Q. Linoleic acid-grafted chitosan oligosaccharide micelles for intracellular drug delivery and reverse drug resistance of tumor cells. Int. J. Biol. Macromol. 2011, 48, 215–222.
[133]
Srinophakun, T.; Boonmee, J. Preliminary study of conformation and drug release mechanism of doxorubicin-conjugated glycol chitosan, via cis-aconityl linkage, by molecular modeling. Int. J. Mol. Sci. 2011, 12, 1672–1683.
[134]
Li, Z.G.; Li, X.Y.; Cao, Z.X.; Xu, Y.Z.; Lin, H.J.; Zhao, Y.L.; Wei, Y.Q.; Qian, Z.Y. Camptothecin nanocolloids based on N,N,N-trimethyl chitosan: Efficient suppression of growth of multiple myeloma in a murine model. Oncol. Rep. 2012, 27, 1035–1040.
[135]
Jiang, G.B.; Lin, Z.T.; Xu, X.J.; Zhang, H.; Song, K. Stable nanomicelles based on chitosan derivative: In vitro antiplatelet aggregation and adhesion properties. Carbohydr. Polym. 2012, 88, 232–238, doi:10.1016/j.carbpol.2011.11.089.
[136]
Sonaje, K.; Lin, K.J.; Tseng, M.T.; Wey, S.P.; Su, F.Y.; Chuang, E.Y.; Hsu, C.W.; Chen, C.T.; Sung, H.W. Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins. Biomaterials 2011, 32, 8712–8721.
[137]
Lin, Z.T.; Song, K.; Bin, J.P.; Liao, Y.L.; Jiang, G.B. Characterization of polymer micelles with hemocompatibility based on N-succinyl-chitosan grafting with long chain hydrophobic groups and loading aspirin. J. Mater. Chem. 2011, 21, 19153–19165.
[138]
Niers, T.M.H.; Klerk, C.P.W.; DiNisio, M.; van Noorden, C.J.F.; Buller, H.R.; Reitsma, P.H.; Richel, D.J. Mechanisms of heparin induced anti-cancer activity in experimental cancer models. Crit. Rev. Oncol. Hematol. 2007, 61, 195–207.
[139]
Karti, S.S.; Ovali, E.; Ozgur, O.; Yilmaz, M.; Sonmez, M.; Ratip, S.; Ozdemir, F. Induction of apoptosis and inhibition of growth of human hepatoma HepG2 cells by heparin. HepatoGastroenterology 2003, 50, 1864–1866.
[140]
Wang, Y.; Xin, D.C.; Liu, K.J.; Zhu, M.Q.; Xiang, J.N. Heparin-paclitaxel conjugates as drug delivery system: Synthesis, self-assembly property, drug release, and antitumor activity. Bioconjug. Chem. 2009, 20, 2214–2221, doi:10.1021/bc8003809.
[141]
Park, I.K.; Kim, Y.J.; Tran, T.H.; Huh, K.M.; Lee, Y.K. Water-soluble heparin-PTX conjugates for cancer targeting. Polymer 2010, 51, 3387–3393, doi:10.1016/j.polymer.2010.05.030.
[142]
Li, L.; Moon, H.T.; Park, J.Y.; Heo, Y.J.; Choi, Y.; Tran, T.H.; Lee, Y.K.; Kim, S.Y.; Huh, K.M. Heparin-based self-assembled nanoparticles for photodynamic therapy. Macromol. Res. 2011, 19, 487–494, doi:10.1007/s13233-011-0505-9.
[143]
Cho, H.J.; Yoon, I.S.; Yoon, H.Y.; Koo, H.; Jin, Y.J.; Ko, S.H.; Shim, J.S.; Kim, K.; Kwon, I.C.; Kim, D.D. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. Biomaterials 2012, 33, 1190–1200.
[144]
Wu, J.L.; Liu, C.G.; Wang, X.L.; Huang, Z.H. Preparation and characterization of nanoparticles based on histidine-hyaluronic acid conjugates as doxorubicin carriers. J. Mater. Sci. Mater. Med. 2012, 23, 1921–1929, doi:10.1007/s10856-012-4665-8.
[145]
Jin, Y.J.; Termsarasab, U.; Ko, S.H.; Shim, J.S.; Chong, S.; Chung, S.J.; Shim, C.K.; Cho, H.J.; Kim, D.D. Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma. Pharma. Res. 2012, 29, 3443–3454, doi:10.1007/s11095-012-0839-9.
Saravanakumar, G.; Choi, K.Y.; Yoon, H.Y.; Kim, K.; Park, J.H.; Kwon, I.C.; Park, K. Hydrotropic hyaluronic acid conjugates: Synthesis, characterization, and implications as a carrier of paclitaxel. Int. J. Pharm. 2010, 394, 154–161, doi:10.1016/j.ijpharm.2010.04.041.
[148]
Shen, Y.; Wang, B.H.; Lu, Y.; Ouahab, A.; Li, Q.; Tu, J.S. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery. Int. J. Pharm. 2011, 414, 233–243, doi:10.1016/j.ijpharm.2011.04.049.
[149]
Manju, S.; Sreenivasan, K. Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. J. Colloid Interface Sci. 2011, 359, 318–325, doi:10.1016/j.jcis.2011.03.071.
[150]
Choi, K.Y.; Min, K.H.; Yoon, H.Y.; Kim, K.; Park, J.H.; Kwon, I.C.; Choi, K.; Jeong, S.Y. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials 2011, 32, 1880–1889, doi:10.1016/j.biomaterials.2010.11.010.
[151]
Bader, R.A.; Silvers, A.L.; Zhang, N. Polysialic acid-based micelles for encapsulation of hydrophobic drugs. Biomacromolecules 2011, 12, 314–320, doi:10.1021/bm1008603.
[152]
Li, N.; Li, X.R.; Zhou, Y.X.; Li, W.J.; Zhao, Y.; Ma, S.J.; Li, J.W.; Gao, Y.J.; Liu, Y.; Wang, X.L.; et al. The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier. Biomaterials 2012, 33, 8881–8892, doi:10.1016/j.biomaterials.2012.08.047.
[153]
Ha, W.; Wu, H.; Wang, X.L.; Peng, S.L.; Ding, L.S.; Zhang, S.; Li, B.J. Self-aggregates of cholesterol-modified carboxymethyl konjac glucomannan conjugate: Preparation, characterization, and preliminary assessment as a carrier of etoposide. Carbohydr. Polym. 2011, 86, 513–519, doi:10.1016/j.carbpol.2011.04.083.
[154]
Ferreira, S.A.; Pereira, P.; Sampaio, P.; Coutinho, P.J.G.; Gama, F.M. Supramolecular assembled nanogel made of mannan. J. Colloid Interface Sci. 2011, 361, 97–108, doi:10.1016/j.jcis.2011.05.020.
[155]
Ferreira, S.A.; Coutinho, P.J.G.; Gama, F.M. Self-assembled nanogel made of mannan: Synthesis and characterization. Langmuir 2010, 26, 11413–11420, doi:10.1021/la100903j.
[156]
De Medeiros Modolon, S.; Otsuka, I.; Fort, S.; Minatti, E.; Borsali, R.; Halila, S. Sweet block copolymer nanoparticles: Preparation and self-assembly of fully oligosaccharide-based amphiphile. Biomacromolecules 2012, 13, 1129–1135, doi:10.1021/bm3000138.
[157]
Niu, J.X.; Su, Z.G.; Xiao, Y.Y.; Huang, A.W.; Li, H.Y.; Bao, X.; Li, S.; Chen, Y.A.; Sun, M.J.; Ping, Q.N. Octreotide-modified and pH-triggering polymeric micelles loaded with doxorubicin for tumor targeting delivery. Eur. J. Pharm. Sci. 2012, 45, 216–226.
[158]
Caliceti, P.; Veronese, F.M. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Adv. Drug Deliv. Rev. 2003, 55, 1261–1277, doi:10.1016/S0169-409X(03)00108-X.
[159]
Gregoriadis, G.; Jain, S.; Papaioannou, I.; Laing, P. Improving the therapeutic efficacy of peptides and proteins: A role for polysialic acids. Int. J. Pharm. 2005, 300, 125–130, doi:10.1016/j.ijpharm.2005.06.007.
[160]
Knop, K.; Hoogenboom, R.; Fischer, D.; Schubert, U.S. Poly(ethylene glycol) in drug delivery: Pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. 2010, 49, 6288–6308, doi:10.1002/anie.200902672.
[161]
Hong, R.L.; Huang, C.J.; Tseng, Y.L.; Pang, V.F.; Chen, S.T.; Liu, J.J.; Chang, F.H. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: Is surface coating with polyethylene glycol beneficial? Clin. Cancer Res. 1999, 5, 3645–3652.
[162]
Holland, J.W.; Hui, C.; Cullis, P.R.; Madden, T.D. Poly(ethylene glycol)—Lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. Biochemistry 1996, 35, 2618–2624.
[163]
Erbacher, P.; Bettinger, T.; Belguise-Valladier, P.; Zou, S.; Coll, J.L.; Behr, J.P.; Remy, J.S. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J. Gene Med. 1999, 1, 210–222, doi:10.1002/(SICI)1521-2254(199905/06)1:3<210::AID-JGM30>3.0.CO;2-U.
[164]
Jain, S.; Hreczuk-Hirst, D.H.; McCormack, B.; Mital, M.; Epenetos, A.; Laing, P.; Gregoriadis, G. Polysialylated insulin: Synthesis, characterization and biological activity in vivo. Biochim. Biophys. Acta 2003, 1622, 42–49, doi:10.1016/S0304-4165(03)00116-8.
[165]
Fernandes, A.I.; Gregoriadis, G. Polysialylated asparaginase: Preparation, activity and pharmacokinetics. Biochim. Biophys. Acta 1997, 1341, 26–34, doi:10.1016/S0167-4838(97)00056-3.
[166]
Fernandes, A.I.; Gregoriadis, G. The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: Implication in its pharmacokinetics. Int. J. Pharm. 2001, 217, 215–224, doi:10.1016/S0378-5173(01)00603-2.
[167]
Fernandes, A.G. G FC41 catalase-polysialic acid conjugates. Eur. J. Pharma. Sci. 1994, 2, 111, doi:10.1016/0928-0987(94)90150-3.
[168]
Fernandes, A.I.; Gregoriadis, G. Synthesis, characterization and properties of sialylated catalase. Biochim. Biophys. Acta 1996, 1293, 90–96, doi:10.1016/0167-4838(95)00227-8.
[169]
Kim, J.K.; Won, Y.W.; Lim, K.S.; Kim, Y.H. Low-molecular-weight methylcellulose-based thermo-reversible gel/pluronic micelle combination system for local and sustained docetaxel delivery. Pharma. Res. 2012, 29, 525–534, doi:10.1007/s11095-011-0581-8.
[170]
Wang, X.; Chen, C.J.; Huo, D.; Qian, H.Q.; Ding, Y.; Hu, Y.; Jiang, X.Q. Synthesis of beta-cyclodextrin modified chitosan-poly(acrylic acid) nanoparticles and use as drug carriers. Carbohydr. Polym. 2012, 90, 361–369, doi:10.1016/j.carbpol.2012.05.052.
[171]
Na, K.; Lee, K.H.; Bae, Y.H. pH-Sensitivity and pH-dependent interior structural change of self-assembled hydrogel nanoparticles of pullulan acetate/oligo-sulfonamide conjugate. J. Contr. Release 2004, 97, 513–525.
[172]
Gong, X.Y.; Yin, Y.H.; Huang, Z.J.; Lu, B.; Xu, P.H.; Zheng, H.; Xiong, F.L.; Xu, H.X.; Xiong, X.; Gu, X.B. Preparation, characterization and in vitro release study of a glutathione-dependent polymeric prodrug cis-3-(9H-purin-6-ylthio)-acrylic acid-graft-carboxymethyl chitosan. Int. J. Pharm. 2012, 436, 240–247, doi:10.1016/j.ijpharm.2012.06.043.
[173]
Zheng, H.; Rao, Y.; Yin, Y.H.; Xiong, X.O.; Xu, P.H.; Lu, B. Preparation, characterization, and in vitro drug release behavior of 6-mercaptopurine-carboxymethyl chitosan. Carbohydr. Polym. 2011, 83, 1952–1958, doi:10.1016/j.carbpol.2010.10.069.
[174]
Hirakura, T.; Nomura, Y.; Aoyama, Y.; Akiyoshi, K. Photoresponsive nanogels formed by the self-assembly of spiropyrane-bearing pullulan that act as artificial molecular chaperones. Biomacromolecules 2004, 5, 1804–1809, doi:10.1021/bm049860o.
[175]
Patnaik, S.; Sharma, A.K.; Garg, B.S.; Gandhi, R.P.; Gupta, K.C. Photoregulation of drug release in azo-dextran nanogels. Int. J. Pharm. 2007, 342, 184–193, doi:10.1016/j.ijpharm.2007.04.038.
[176]
Cai, L.L.; Liu, P.; Li, X.; Huang, X.; Ye, Y.Q.; Chen, F.Y.; Yuan, H.; Hu, F.Q.; Du, Y.Z. RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells. Int. J. Nanomed. 2011, 6, 3499–3508.
[177]
Tan, Y.L.; Liu, C.G. Preparation and characterization of self-assemblied nanoparticles based on folic acid modified carboxymethyl chitosan. J. Mater. Sci. Mater. Med. 2011, 22, 1213–1220, doi:10.1007/s10856-011-4302-y.
Nayebsadrian, M.; Varshosaz, J.; Hassanzadeh, F.; Sadeghi, H.; Banitalebi, M.; Rostami, M. Screening the most effective variables on physical properties of folate-targeted dextran/retinoic acid micelles by taguchi design. J. Nanomater. 2012, 2012, 860691:1–860691:7.
[180]
Dionisio, M.; Cordeiro, C.; Remunan-Lopez, C.; Seijo, B.; Rosa da Costa, A.M.; Grenha, A. Pullulan-based nanoparticles as carriers for transmucosal protein delivery. Eur. J. Pharm. Sci. 2013, doi:10.1016/j.ejps.2013.04.018.
